{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:29:09Z","timestamp":1765826949308},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T00:00:00Z","timestamp":1287964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2474-11-247","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T07:14:27Z","timestamp":1289891667000},"source":"Crossref","is-referenced-by-count":21,"title":["Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database"],"prefix":"10.1186","volume":"11","author":[{"given":"Hans","family":"Petri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Maldonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah Jamie","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,25]]},"reference":[{"key":"993_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1185\/030079905X41426","volume":"21","author":"S Gough","year":"2005","unstructured":"Gough S: Post-marketing surveillance: a UK\/European perspective. Curr Med Res Opin. 2005, 21: 565-70. 10.1185\/030079905X41426.","journal-title":"Curr Med Res Opin"},{"key":"993_CR2","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/eurheartj\/ehm209","volume":"28","author":"JS Borer","year":"2007","unstructured":"Borer JS, Pouleur H, Abadie E, Follath F, Wittes J, Pfeffer MA, Pitt B, Zannad F: Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. Eur Heart J. 2007, 28: 1904-9. 10.1093\/eurheartj\/ehm209.","journal-title":"Eur Heart J"},{"key":"993_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/pds.1207","volume":"15","author":"L Goldkind","year":"2006","unstructured":"Goldkind L, Laine L: A systematic review of NSAIDs withdrawn from the market due to hepatoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol Drug Saf. 2006, 15: 213-220. 10.1002\/pds.1207.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"993_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00296-008-0650-4","volume":"28","author":"W Jaksch","year":"2008","unstructured":"Jaksch W, Dejaco C, Schirmer M: Four years after withdrawal of rofecoxib: where do we stand today?. Rheumatol Int. 2008, 28: 1187-1195. 10.1007\/s00296-008-0650-4.","journal-title":"Rheumatol Int"},{"key":"993_CR5","first-page":"88","volume-title":"Good Pharmacovigilance Practice Guide","author":"Medicines and Healthcare products Regulatory Agency","year":"2009","unstructured":"Medicines and Healthcare products Regulatory Agency: Good Pharmacovigilance Practice Guide. 2009, London: Pharmaceutical Press, 88-89."},{"key":"993_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMp0810755","volume":"360","author":"S Okie","year":"2009","unstructured":"Okie S: A to-do list for the new FDA commissioner. N Engl J Med. 2009, 360: 1373-1378. 10.1056\/NEJMp0810755.","journal-title":"N Engl J Med"},{"key":"993_CR7","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","volume":"98","author":"JA Berlin","year":"2008","unstructured":"Berlin JA, Glasser SC, Ellenberg SS: Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Pub Health. 2008, 98: 1366-1371. 10.2105\/AJPH.2007.124537.","journal-title":"Am J Pub Health"},{"key":"993_CR8","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002-1","unstructured":"Doran MF, Crowson CS, Pound GR, O' Fallon M, Gabriel SE: Frequency of infection in patients with rheumatoid arthritis compared with controls. Arthr Rheumat. 2002-1, 46: 2287-93. 10.1002\/art.10524.","journal-title":"Arthr Rheumat"},{"key":"993_CR9","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002-2","unstructured":"Doran MF, Crowson CS, Pond GR: Predictors of infection in rheumatoid arthritis. Arthr Rheum. 2002-2, 46: 2294-2300. 10.1002\/art.10529.","journal-title":"Arthr Rheum"},{"key":"993_CR10","first-page":"906","volume":"29","author":"L Bj\u00f6rnodal","year":"2002","unstructured":"Bj\u00f6rnodal L, Baeklund E, Yin L: Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. J Rheumatology. 2002, 29: 906-912.","journal-title":"J Rheumatology"},{"key":"993_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB: Cardiovascular morbidity and mortality in women with RA. Circulation. 2003, 107: 1303-1307. 10.1161\/01.CIR.0000054612.26458.B2.","journal-title":"Circulation"},{"key":"993_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009740310004621","volume":"33","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jacobsson LT: Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2004, 33: 65-72. 10.1080\/03009740310004621.","journal-title":"Scand J Rheumatol"},{"key":"993_CR13","first-page":"1196","volume":"30","author":"D Watson","year":"2003","unstructured":"Watson D, Rhodes T, Guess H: All cause mortality and vascular events in RA, Osteoarthritis, or no arthritis in the UK. J Rheumatol. 2003, 30: 1196-1202.","journal-title":"J Rheumatol"},{"key":"993_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","volume":"21","author":"A Young","year":"2007","unstructured":"Young A, Koduri G: Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007, 21: 907-927. 10.1016\/j.berh.2007.05.007.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"993_CR15","volume-title":"Health research data for the real world: the Marketscan databases","author":"DM Adamson","year":"2008","unstructured":"Adamson DM, Chang S, Hansen LG: Health research data for the real world: the Marketscan databases. 2008, New York: Thompson Healthcare"},{"key":"993_CR16","volume-title":"Proceedings of the Twenty-Nineth Annual SAS Users Group International Conference","author":"LS Parsons","year":"2004","unstructured":"Parsons LS: Performing a 1:N Case-Control Match on Propensity Score. Proceedings of the Twenty-Nineth Annual SAS Users Group International Conference. 2004, Cary, NC: SAS Institute Inc."},{"key":"993_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/ard.2003.018101","volume":"63","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jarenros A, Jacobsson L: Increased incidence of CV disease in RA. Ann Rheum. 2004, 63: 952-955. 10.1136\/ard.2003.018101.","journal-title":"Ann Rheum"},{"key":"993_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","volume":"21","author":"A Young","year":"2007","unstructured":"Young A, Koduri G: Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007, 21: 907-927. 10.1016\/j.berh.2007.05.007.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"993_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/ard.60.5.443","volume":"60","author":"KS Steen","year":"2001","unstructured":"Steen KS, Lems WF, Aertsen J, Bezemer D, Dijkmans BA: Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis. Ann Rheum Dis. 2001, 60: 443-447. 10.1136\/ard.60.5.443.","journal-title":"Ann Rheum Dis"},{"key":"993_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/ard.2006.068015","volume":"67","author":"KS Steen","year":"2008","unstructured":"Steen KS, Nurmohamed MT, Visman I, Heijerman M, Boers M, Dijkmans BA, Lems WF: Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 256-259. 10.1136\/ard.2006.068015.","journal-title":"Ann Rheum Dis"},{"key":"993_CR21","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002-2","unstructured":"Doran MF, Crowson CS, Pond GR: Predictors of infection in rheumatoid arthritis. Arthr Rheum. 2002-2, 46: 2294-2300. 10.1002\/art.10529.","journal-title":"Arthr Rheum"},{"key":"993_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.22504","volume":"56","author":"J Curtis","year":"2007","unstructured":"Curtis J, Patkar N, Xie A: Risk of serious bacterial infections among rheumatoid arthritis patients exposed to TNF-a antagonists. Arthr& Rheumatism. 2007, 56: 1125-1133.","journal-title":"Arthr& Rheumatism"},{"key":"993_CR23","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S: Infections in patients with rheumatoid arthritis treated with biologic agents. Arthr& Rheumatism. 2005, 52: 3403-3412.","journal-title":"Arthr& Rheumatism"},{"key":"993_CR24","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Van Staa","year":"2006","unstructured":"Van Staa TP, Geusens P, Bijlsma JW, Leufekens HG, Cooper C: Clinical assessment of the long-term risk of practure in patients with rheumatoid arthritis. Arthritis Rheum. 2006, 54: 3104-12. 10.1002\/art.22117.","journal-title":"Arthritis Rheum"},{"key":"993_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","volume":"21","author":"K Michaud","year":"2007","unstructured":"Michaud K, Wolfe F: Comorbidities in rheumatoid arthritis. Best Pract Res Clin Pharmacol. 2007, 21: 885-906. 10.1016\/j.berh.2007.06.002.","journal-title":"Best Pract Res Clin Pharmacol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-11-247\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-11-247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T13:50:12Z","timestamp":1548165012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-11-247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-11-247","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,25]]},"article-number":"247"}}